Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon

Journal of Clinical Endocrinology and Metabolism

Volumn 63, Issue 5, 1986, Pages 1086-1090

  Burman, Pia ^b   Tôtterman, Thomas H ^a   Oberg K ^b   Karlsson, F Anders ^b  

^a Department of Oncology   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; RADIOISOTOPE; RECOMBINANT ALPHA INTERFERON; RECOMBINANT GAMMA INTERFERON; TECHNETIUM 99M; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROXINE;

CARCINOID; CLINICAL ARTICLE; DIAGNOSIS; DIGESTIVE SYSTEM; DRUG ACCUMULATION; DRUG THERAPY; ENDOCRINE SYSTEM; HASHIMOTO DISEASE; HELPER CELL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE SUBPOPULATION; PHARMACOKINETICS; PRIORITY JOURNAL; SUPPRESSOR CELL; THERAPY; THYROID MICROSOME ANTIBODY; THYROTOXICOSIS;

ADULT; AGED; AUTOIMMUNE DISEASES; FEMALE; HLA-DR ANTIGENS; HUMAN; INTERFERON TYPE I; LONG-TERM CARE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; THYROID FUNCTION TESTS; THYROID GLAND;

EID: 0022981391     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-63-5-1086     Document Type: Article

References (17)

1. Golub SH 1984 Immunological and therapeutic effects of interferon treatment of cancer patients. Clin Immunol Allergy 4:377
2. Trinchieri G, Santoli D, Koprowski H 1978 Spontaneous cell-mediated cytotoxicity in humans; role of interferon and immunoglobulins. J Immunol 120:1849
3. Fridman WH, Gresser I, Bandu MT, Aguet M, Neauport-Sautes C 1980 Interferon enhances the expression of FC7 receptors. J Immunol 124:2436
4. Farrar WL, Johnson HM, Farrar JJ 1981 Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2. J Immunol 126:1120
5. Jackson RA, Morris MA, Haynes BF, Eisenbarth GS 1982 Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus. N Engl J Med 132:3011
6. Jackson RA, Haynes BF, Burch WM, Shimizu K, Bowring MA, Eisenbarth GS 1984 Ia+ T cells in new onset Graves’ disease. J Clin Endocrinol Metab 59:187
7. Rosa F, Fellous M 1984 The effect of gamma-interferon on MHC antigens. Immunol Today 5:261
8. Hanafusa T, Pujol-Borrel R, Chiovato L, Russell RCG, Doniach D, Bottazzo GF 1983 Aberrant expression of HLA-DR antigen on thyrocytes in Graves’ disease: relevance for autoimmunity. Lancet 2:1111
9. Jansson R, Karlsson FA, Forsum U 1984 Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves’ thyrotoxicosis, Hashimoto’s thyroiditis and nodular colloid goitre. Clin Exp Immunol 58:264
10. Bottazzo GF, Pujol-Borrel R, Hanafusa T, Feldmann M 1983 Hypothesis: role of aberrant HLA-DR expression and antigen presentation in the induction of endocrine autoimmunity. Lancet 2:1115
11. 8 units per ml. J Gen Virol 39:541
12. Bjøro T, Gaarder PI, Smeland EB, Kornstad L 1984 Thyroid antibodies in blood donors: prevalence and clinical significance. Acta Endocrinol (Copenh) 105:324
13. Lazarus JH, Burr ML, McGregor AM, Weetman AP, Ludgate M, Woodhead JS, Hall R 1984 The prevalence and progression of autoimmune thyroid disease in the elderly. Acta Endocrinol (Copenh) 106:199
14. Burman P, Karlsson FA, Öberg K, Alm G 1985 Autoimmune thyroid disease in interferon-treated patients. Lancet 2:100
15. Londei M, Lamb JR, Bottazzo GF, Feldmann M 1984 Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature 312:639
16. Fentiman IS, Thomas BS, Balkwill FR, Rubens RD, Hayward JL 1985 Primary hypothyroidism associated with interferon therapy of breast cancer. Lancet 1:1166
17. Bhakri H, Sriskandar K, Davies T, Pettingale K, Tee D 1985 Recombinant gamma interferon and autoimmune thyroid disease. Lancet 2:457